TAMLYNN EVANS: Open Payments
NPI 1336113216 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,261 in 21 payments from 4 companies in 2025. Trend: 2023 $27,312 · 2024 $19,535 · 2025 $10,261
Speaker / faculty: $9,809Food & beverage: $336Travel & lodging: $116
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $5,801 |
| ABBVIE INC. | 8 | $4,224 |
| E.R. Squibb & Sons, L.L.C. | 1 | $120 |
| Neurocrine BioSciences, Inc. | 1 | $117 |
Products named: REXULTI, VRAYLAR, COBENFY, INGREZZA.
Industry payments across MI — which companies pay providers there.
